Adherence to Psoriasis Therapies - 23/05/24
Doi : 10.1016/j.det.2024.02.010
Kawaiola C. Aoki, MAS a, Summer Wong, BS a, Jessica Q. Duong, BS a, Steven R. Feldman, MD, PhD b, ⁎ 
a Department of Dermatology, Center for Dermatology Research, Wake Forest University School of Medicine, 4618 Country Club Road, Winston-Salem, NC 27104, USA
b Department of Dermatology, Pathology, and Social Sciences & Health Policy, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1071, USA
∗Corresponding author. Department of Dermatology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1071.Department of DermatologyWake Forest University School of MedicineMedical Center BoulevardWinston-SalemNC27157-1071
Résumé |
Understanding the underlying causes of nonadherence among patients with psoriasis and adopting strategies to address these issues may allow providers to share responsibility and work alongside patients to overcome these barriers. The review explores patient adherence to different types of psoriasis treatment, suggestions for interventions to overcome barriers, and methods to promote adherence that have been published in the literature.
Le texte complet de cet article est disponible en PDF.Keywords : Adherence, Barriers, Compliance, Interventions, Nonadherence, Persistence, Primary adherence, Secondary adherence
Plan
© 2024
Elsevier Inc. Tous droits réservés.
Vol 42 - N° 3
P. 495-506 - juillet 2024 Retour au numéro
Article précédent
- Immune Checkpoint Inhibitor-Induced Psoriasis : Diagnosis, Management, and a Review of Cases
- Jolanta J. Pach, Nina Mbonu, Shaman Bhullar, Jeffrey M. Cohen, Jonathan S. Leventhal
- Disparities in Care for Psoriasis
- Roman Drozdowski, Neelesh Jain, Christian Gronbeck, Hao Feng
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?